MANNKIND CORP Income Taxes Paid
MANNKIND CORP (MNKD) reported Income Taxes Paid of $240.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2020-02-25
- MANNKIND CORP income taxes paid for fiscal 2018 was $240.00K, a 370.59% increase from fiscal 2017.
- MANNKIND CORP income taxes paid for fiscal 2017 was $51.00K.
| Period end | Income Taxes Paid 12 month | Income Taxes Paid 244 month | Income Taxes Paid 247 month | Income Taxes Paid 250 month | Income Taxes Paid 253 month | Income Taxes Paid 256 month | Income Taxes Paid 259 month | Income Taxes Paid 263 month | Income Taxes Paid 265 month | Income Taxes Paid 268 month | Income Taxes Paid 271 month | Income Taxes Paid 275 month | Income Taxes Paid 277 month | Income Taxes Paid 280 month | Income Taxes Paid 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $240.00K 10-K · filed 2020-02-25 | ||||||||||||||
| 2017-12-31 | $51.00K 10-K · filed 2019-02-26 | ||||||||||||||
| 2014-09-30 | $26.00K 10-Q · filed 2014-11-10 | ||||||||||||||
| 2014-06-30 | $26.00K 10-Q · filed 2014-08-11 | ||||||||||||||
| 2014-03-31 | $26.00K 10-Q · filed 2014-05-12 | ||||||||||||||
| 2013-12-31 | $26.00K 10-K · filed 2014-03-03 | ||||||||||||||
| 2013-09-30 | $26.00K 10-Q · filed 2013-11-12 | ||||||||||||||
| 2013-06-30 | $26.00K 10-Q · filed 2013-08-09 | ||||||||||||||
| 2013-03-31 | $26.00K 10-Q · filed 2013-05-10 | ||||||||||||||
| 2012-12-31 | $26.00K 10-K · filed 2013-03-18 | ||||||||||||||
| 2012-09-30 | $26.00K 10-Q · filed 2012-11-09 | ||||||||||||||
| 2012-06-30 | $26.00K 10-Q · filed 2012-08-09 | ||||||||||||||
| 2012-03-31 | $26.00K 10-Q · filed 2012-05-10 | ||||||||||||||
| 2011-12-31 | $26.00K 10-K · filed 2012-03-15 | ||||||||||||||
| 2011-09-30 | $26.00K 10-Q · filed 2011-11-04 | ||||||||||||||
| 2011-06-30 | $26.00K 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |